The 20 Best Metastatic Uveal Melanoma Doctors Near Me in baltimore, MD

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology. Dr. Handa is currently accepting new patients.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, and Melanoma of the Eye. Dr. Lipson is board certified in American Board Of Internal Medicine. Dr. Lipson is currently accepting new patients.

Harry Quon is an Otolaryngologist and a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Quon is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Swallowing Difficulty, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Laryngectomy. Dr. Quon is board certified in American Board Of Radiology. Dr. Quon is currently accepting new patients.

Akrit Sodhi is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Sodhi is rated as an Advanced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration. Dr. Sodhi is board certified in American Board Of Ophthalmology. Dr. Sodhi is currently accepting new patients.

David Kamson is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Kamson is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Metastatic Brain Tumor, Glioblastoma, Glioma, and Hormone Replacement Therapy (HRT). Dr. Kamson is board certified in American Board Of Psychiatry And Neurology. Dr. Kamson is currently accepting new patients.

Petr Hausner is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Hausner is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, and Melanoma. Dr. Hausner is board certified in American Board Of Internal Medicine - Medical Oncology, 1998. Dr. Hausner is currently accepting new patients.

Hibba Rehman is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Rehman is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Melanoma, and Bone Marrow Aspiration. Dr. Rehman is board certified in American Board Of Internal Medicine - Medical Oncology, 2017 and American Board Of Internal Medicine - Hematology, 2017. Dr. Rehman is currently accepting new patients.

Dr. Warrier is a medical oncologist at Johns Hopkins who specializes in caring for patients with high-risk and advanced skin cancers (e.g., melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma). This includes expertise with state-of-the-art immunotherapy, targeted therapy, and chemotherapy treatments, as well as optimal surveillance approaches for cancer. Dr. Warrier’s clinical practice is in Baltimore, Maryland. Dr. Warrier received his medical degree in 2017 from the University of Louisville School of Medicine, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The University of Michigan and spent an additional year serving as chief resident. He subsequently completed a Medical Oncology fellowship at Johns Hopkins University, where he also served as chief medical oncology fellow. As a member of the Johns Hopkins Melanoma/Skin Cancer and Cancer Immunology Programs, Dr. Warrier is actively engaged in research focused on improving outcomes for patients with skin cancers. As part of his research, he helps develop and lead innovative clinical trials focused on developing better, and safer, cancer treatments and monitoring approaches. Dr. Warrier is additionally interested in improving cancer care delivery through digital health initiatives. He is currently helping lead study and development of a novel digital patient navigation platform aiming to help patients with melanoma around the country better understand their diagnosis, get connected with melanoma experts, and learn about clinical trials. In addition to his clinical and research activities, Dr. Warrier is a dedicated educator. Dr. Warrier is regularly engaged in teaching medical trainees and other health professionals. He has also published several manuscripts focused on patient education in JAMA Internal Medicine. Dr. Warrier is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His clinical expertise encompasses Melanoma and Metastatic Uveal Melanoma. Dr. Warrier is board certified in American Board Of Internal Medicine. Dr. Warrier is currently accepting new patients.

Fernando Arevalo is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Arevalo is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy. Dr. Arevalo is currently accepting new patients.

Aliyah Pabani is an Oncologist and an Otolaryngologist practicing medicine in Baltimore, Maryland. Dr. Pabani is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Small Cell Lung Cancer (SCLC). Dr. Pabani is board certified in Royal College Of Physicians And Surgeons Of Canada. Dr. Pabani is currently accepting new patients.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.

Franco Verde is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Verde is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Nodules, Gas Bloat Syndrome, and Visceromegaly. Dr. Verde is currently accepting new patients.

Shannath Merbs is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Merbs is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Eyelid Drooping, Ptosis, Conjunctivitis (Pink Eye), Blocked Tear Duct, and Osteotomy. Dr. Merbs is currently accepting new patients.

Jacob Heng is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Heng is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His clinical expertise encompasses Familial Exudative Vitreoretinopathy, Metastatic Uveal Melanoma, Endophthalmitis, and Uveal Melanoma.

Jonaphine Mata is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Mata is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. Her clinical expertise encompasses Metastatic Uveal Melanoma.

David Reisner is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Reisner is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Wandering Spleen, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer. Dr. Reisner is currently accepting new patients.

Harvinder Singh is a Hematologist and an Oncologist practicing medicine in Glen Burnie, Maryland. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Plasmacytoma, Urothelial Cancer, and Bone Marrow Aspiration. Dr. Singh is board certified in ABIM - Medical Oncology - Medical Oncology, 2000, American Board Of Internal Medicine - Internal Medicine, 1997, and ABIM - Hematology - Hematology, 2000. Dr. Singh is currently accepting new patients.

Ana Kiess is a Radiation Oncologist practicing medicine in Lutherville, Maryland. Dr. Kiess is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy. Dr. Kiess is board certified in American Board Of Radiology. Dr. Kiess is currently accepting new patients.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine. Dr. Sharfman is currently accepting new patients.

Vishal Jindal is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Jindal is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Atheroembolic Renal Disease, Thrombocytopenia, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Jindal is currently accepting new patients.